Biblio Discovery — Demo Discovery Service

36 hasil untuk "David Epstein"

Menampilkan 1–20 · 0,92 detik · RSS

  1. Artikel Jurnal

    Pricing and reimbursement of off-patent medicines dispensed in community pharmacies

    David Epstein

    Gaceta Sanitaria, Vol. 39 · 2025 · Spanyol · DOAJ Scopus

    Objective: After expiry of the patent, price competition can lead to savings. However, in Spain, competition in the retail price of prescription off-patent medicines in pharmacies is rare, while large discounts are negotiated in the wholesale market. Some countries have moved from “competition by…

  2. Artikel Jurnal

    Why Nurture Is Natural Too

    Samuel David Epstein

    Biolinguistics, Vol. 10 · 2016 · Inggris · DOAJ Scopus

  3. Artikel Jurnal

    Comparing methods for handling missing cost and quality of life data in the Early Endovenous Ablation in Venous Ulceration trial

    Modou Diop; David Epstein

    Cost Effectiveness and Resource Allocation, Vol. 20 No. 1 · 2022 · Inggris · DOAJ Scopus

    Abstract Objectives This study compares methods for handling missing data to conduct cost-effectiveness analysis in the context of a clinical study. Methods Patients in the Early Endovenous Ablation in Venous Ulceration (EVRA) trial had between 1 year and 5.5 years (median 3 years) of follow-up…

  4. Artikel Jurnal

    ¿Qué revela sobre el sistema público sanitario la contratación de un seguro de salud privado?

    David Epstein; Dolores Jiménez-Rubio

    Gaceta Sanitaria, Vol. 33 No. 5 · 2019 · Spanyol · DOAJ Scopus

    Resumen: Objetivo: Este estudio examina la elección individual de seguro sanitario privado en España. La elección del seguro privado revela los atributos del sistema sanitario que son más valorados por la población, así como la capacidad de respuesta de este en relación a esas preferencias. Método…

  5. Artikel Jurnal

    The price of innovation - the role of drug pricing in financing pharmaceutical innovation. A conceptual framework

    Santiago G. Moreno; David Epstein

    Journal of Market Access & Health Policy, Vol. 7 No. 1 · 2019 · Inggris · DOAJ Scopus

    The debate on drug prices has reached new heights with the controversy around the role of prices in promoting innovation. Critics claim that prices of innovative drugs are excessive and argue that lowering prices will not harm the flourishing innovation. On the opposite end, the pharmaceutical…

  6. Artikel Jurnal

    Implications de la mobilité quotidienne dans les stratégies résidentielles transfrontalières

    Samuel Carpentier; David Epstein; Philippe Gerber

    Espace populations sociétés, Vol. 2012 No. 3 · 2013 · Prancis · DOAJ Scopus

    Between 2001 and 2007, nearly 8,000 resi­dents of Luxembourg went to live in Bel­gium, Germany and France though they remained employed in Luxembourg. For the vast majority of these people, this cross-bor­der move implies a growth of commuting distance and can therefore be regarded as a particular…

  7. Artikel Jurnal

    How innovation can be defined, evaluated and rewarded in health technology assessment

    Juan Carlos Rejon-Parrilla; Jaime Espin; David Epstein

    Health Economics Review, Vol. 12 No. 1 · 2022 · Inggris · DOAJ Scopus

    Abstract Background What constitutes innovation in health technologies can be defined and measured in a number of ways and it has been widely researched and published about. However, while many countries mention it as a criterion for pricing or reimbursement of health technologies, countries differ…

  8. Artikel Jurnal

    Hyper-Stain Inspector: A Framework for Robust Registration and Localised Co-Expression Analysis of Multiple Whole-Slide Images of Serial Histology Sections

    Nicholas Trahearn; David Epstein; Ian Cree dkk.

    Scientific Reports, Vol. 7 No. 1 · 2017 · Inggris · DOAJ Scopus

    Abstract In this paper, we present a fast method for registration of multiple large, digitised whole-slide images (WSIs) of serial histology sections. Through cross-slide WSI registration, it becomes possible to select and analyse a common visual field across images of several serial section…

  9. Artikel Jurnal

    How should medicines reimbursement work? The views of Spanish experts

    Juan Carlos Rejon-Parrilla; David Epstein; Daniel Pérez-Troncoso dkk.

    Health Economics, Policy and Law, Vol. 20 · 2025 · Inggris · DOAJ Scopus

    Although the criteria that support reimbursement decisions for medicines are often set by legislation, as is the case in Spain, in many cases neither the definition nor the measurement methods for these criteria are provided. Our goal was to elicit the views of a large sample of Spanish technical…

  10. Artikel Jurnal

    Evaluación económica de la inclusión en el calendario vacunal de 4CMenB (Bexsero®) en España

    Rafael Ruiz-Montero; David Epstein; Bernardo Guzmán Herrador dkk.

    Gaceta Sanitaria, Vol. 34 No. 4 · 2020 · Spanyol · DOAJ Scopus

    Resumen: Introducción: Bexsero® (4CMenB), vacuna contra el meningococo B, fue autorizada en Europa en 2013. En España, a pesar de que el meningococo B es la principal causa de enfermedad meningocócica invasiva (EMI), Bexsero® está recomendada y financiada para pacientes con alto riesgo de EMI pero…

  11. Artikel Jurnal

    Decision uncertainty and value of further research: a case-study in fenestrated endovascular aneurysm repair for complex abdominal aortic aneurysms

    Oriana Ciani; David Epstein; Claire Rothery dkk.

    Cost Effectiveness and Resource Allocation, Vol. 16 No. 1 · 2018 · Inggris · DOAJ Scopus

    Abstract Background Fenestrated endovascular aneurysm repair (fEVAR) is a new approach for complex abdominal aortic aneurysms, limited to a few specialist centers, with limited evidence base. We developed a cost-effectiveness decision model of fEVAR compared to open surgical repair (OSR) to…

  12. Artikel Jurnal

    INES: Interactive tool for construction and extrapolation of partitioned survival models

    Vicente Gimeno-Ballester; Daniel Perez-Troncoso; Antonio Olry-Labry dkk.

    Cost Effectiveness and Resource Allocation, Vol. 21 No. 1 · 2023 · Inggris · DOAJ Scopus

    Abstract Background INES (INteractive model for Extrapolation of Survival and cost) provides an open-access tool powered by R that implements three-state partitioned survival models (PSM). This article describes the properties of the tool, and the situations where INES may or may not be suitable…

  13. Artikel Jurnal

    Overcoming barriers to off-patent drug repurposing: a lifecycle-based policy solutions

    Mario Garcia-Diaz; David Epstein; Jaime Espin

    Frontiers in Pharmacology, Vol. 16 · 2025 · Inggris · DOAJ Scopus

    IntroductionDrug repurposing leverages existing medicines to reduce time and costs for exploring new therapeutic indications. However, off-patent medicines do not provide enough private incentives for investment, and prescribing by active ingredient can be a major barrier. Academics and non-profit…

  14. Artikel Jurnal

    “There is nothing better than participating in this study”: Living the PAPAartis cardiovascular randomised controlled trial

    Nuria Romo-Avilés; Johanna Fröhlich Zapata; Alena Keuneke dkk.

    Contemporary Clinical Trials Communications, Vol. 29 · 2022 · Inggris · DOAJ Scopus

    Qualitative research can bring new dimensions of understanding decision-making process in clinical trials. Participating in a randomized clinical trial requires patients to accept complex information and make decisions in a context of uncertainty. It becomes especially complicated in the case of…

  15. Artikel Jurnal

    Development of the European Healthcare and Social Cost Database (EU HCSCD) for use in economic evaluation of healthcare programs

    Jaime Espín; Zuzana Špacírová; Joan Rovira dkk.

    BMC Health Services Research, Vol. 22 No. 1 · 2022 · Inggris · DOAJ Scopus

    Abstract Introduction Costs are one of the critical factors for the transferability of the results in health technology assessment and economic evaluation. The objective is to develop a cost database at the European level to facilitate cross-border cost comparisons in different settings and…

  16. Artikel Jurnal

    Pricing and reimbursement mechanisms for advanced therapy medicinal products in 20 countries

    Juan Carlos Rejon-Parrilla; Jaime Espin; Sarah Garner dkk.

    Frontiers in Pharmacology, Vol. 14 · 2023 · Inggris · DOAJ Scopus

    Introduction: Advanced Therapy Medicinal Products are a type of therapies that, in some cases, hold great potential for patients without an effective current therapeutic approach but they also present multiple challenges to payers. While there are many theoretical papers on pricing and…

  17. Artikel Jurnal Teks lengkap

    Re-expression of IGF-II is important for beta cell regeneration in adult mice.

    Luxian Zhou; Stella Pelengaris; Sylvie Abouna dkk.

    PLoS ONE, Vol. 7 No. 9 · 2012 · Inggris · DOAJ Scopus

    The key factors which support re-expansion of beta cell numbers after injury are largely unknown. Insulin-like growth factor II (IGF-II) plays a critical role in supporting cell division and differentiation during ontogeny but its role in the adult is not known. In this study we investigated the…